HealthVerity and Medeloop partner to accelerate real-world evidence generation with AI-powered analytics

HealthVerity and Medeloop have announced a new partnership aimed at simplifying and accelerating the analysis of real-world data (RWD), supporting faster and more actionable insights across healthcare and life sciences.

HealthVerity provides privacy-protected data exchange technology that connects disparate healthcare datasets to support clinical development, regulatory submissions, and commercial strategy. Medeloop offers AI-powered healthcare analytics, enabling pharmaceutical companies, healthcare providers, and researchers to generate insights by posing natural language questions to complex RWD.

The partnership integrates HealthVerity’s privacy-compliant data ecosystem with Medeloop’s no-code AI Agent Analytics platform to streamline real-world evidence (RWE) generation. The combined solution is intended to support pharmaceutical and biotech companies, academic researchers, healthcare providers, and public health agencies in extracting insights from large-scale, complex RWD.

Through the collaboration, Medeloop’s customers at academic medical centers and health systems gain access to HealthVerity’s ecosystem of more than 200 million de-identified patient records. Using Medeloop’s no-code analytics platform, users can transform written research questions into complete studies and generate actionable insights within minutes, without requiring programming expertise.

Andrew Kress, CEO of HealthVerity, described the partnership as an advance in the accessibility of RWE:

"Previously, generating insights from RWD required extensive teams and months of effort. Now, with this partnership combining our access to large-scale RWD and Medeloop's leading-edge technology, we're enabling researchers and healthcare professionals to directly pose complex questions and receive powerful insights within minutes in a fully transparent, monitored, and human-guided fashion, fundamentally changing the pace and accessibility of data-driven healthcare research."

HealthVerity’s pharmaceutical and biotech clients also benefit from the integration of Medeloop’s analytics platform, enabling the generation of deeper, more targeted insights to support clinical research and commercial decision-making. René Caissie, CEO of Medeloop, stated:

“By integrating the latest innovations in AI Agent Analytics with the richest real-world datasets available, we empower customers to rapidly achieve insights previously out of reach. This partnership accelerates scientific discovery, drives innovation, and helps save lives by enabling faster, more informed decisions that improve public health outcomes.”